New antibody drug tested in fight against sudden, severe lung failure
NCT ID NCT05938036
Summary
This study is testing a new antibody drug called ALT-100 in hospitalized adults with moderate to severe Acute Respiratory Distress Syndrome (ARDS), a life-threatening form of lung failure. The main goals are to see if the drug is safe and if it can help patients breathe without a ventilator sooner and leave the hospital faster. Participants receive a single dose of the drug or a placebo within hours of their ARDS diagnosis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banner University of Arizona
Tucson, Arizona, 85721, United States
Conditions
Explore the condition pages connected to this study.